Naureen Tareen, MD

*** * *** ****** **. Fullerton, California 92835

ad36n2@r.postjobfree.com

Education

LICENSURE: Current: State of California, A064054

Board Certification: Diplomate of American Board of Internal Medicine

CarbonHealth

February 2022-Current

●Medical Provider

Pacific Renal Group August 2016- Current

●Medical Provider

Innovative Skin Medical Center Jan 2007- Current

●Medical Director

T.H.E Clinic September 2014- 2022

●Internal Medicine Provider

Medicine and Nephrology Associates June 2013- June 2016

ProHealth Partners August 2009- Current

●Nephrology Group Practice

Rao Dermatology Sep 2007- Mar 2020

●Dermatology Group Practice

Innovative Skin Medical Center Jan 2007- Current

●Medical Director

Charles. R. Drew University July 2003- July 2014

●Assistant Director: Clinical and Translational Research Center

Charles. R. Drew University July 2003- Current

Clinical Instructor: Department of Internal Medicine

Charles. R. Drew University July 2000 - June 2007

●Attending Physician: Department of Internal Medicine

Veterans Affairs Hospital Westwood

July 2000- June 2003

●Fellowship: Nephrology

King Drew Medical Center July 1999 - June 2000

●Chief Residency: Internal Medicine Department

King Drew Medical Center July 1998 - June 2000

●Residency: Internal Medicine Department

King Drew Medical Center July 1997- June 1998

●Internship: Department of Internal Medicine

University of California, Los Angeles July 1996- June 1997

●Internship: Department of Pathology Wards Worth Medical Center

National Medical School Review Dec 1995- April 1996

●Academic Facilitator

USC Campus of Rancho Los Amigos April 1995- Sep 1995

●Externship: Infectious Diseases

Friendly Hills Hospital

Dec 1993- August 1994

●Externship: ICU

Abrar's Surgery July 1991- Sep 1993

●Family Practice

Holy Family University Hospital July 1987- June 1991

●Residency: Internal Medicine

Holy Family University Hospital

July 1985- June 1987

●Internship: Internal Medicine

Rawalpindi University, Pakistan School of Medicine

July 1981- June 1985

●Graduate: Medicine (M.D.)

Honor and special award

●July 1997- June 98 Outstanding PGY 1 Resident, Department of Internal Medicine, King Drew Medical Center

●July 1998- June 99 Outstanding PGY 11 Resident, Department of Internal Medicine, King Drew Medical Center

●July 1999- June 2000 Chief Resident Award, Department of Internal Medicine, King Drew Medical Center

●July 1999- June 2000 Mary Henry, Compassion and Humanism Award

●Clinical/Research Fellow Nephrology, Veterans Affairs Hospital UCLA

●UCLA School of Medicine Awards

●July 1999 Solomon Scholars Resident Research Award UCLA School of Medicine

●July 1985-- June 86 Student Federation for Poor Patient Award

●July 1980--June 82 Undergraduate Trustee Scholarship, Half Tuition Merit Scholarship

●July 1977- June 79 Quaid Azam Scholarship Federal, Government University Pakistan

Pilot Projects/Clinical Trials

●African American Study of Kidney Disease and Hypertension (AASK TRIAL)

●The Optimal Dose of 25 Hydroxy-Vitamin D (25D) for Activation of Endocrine Effects

●Aggressive vs. Low Dose Inhibition of the Renin-Angiotensin System (RAS) for the Treatment of Microalbuminuria in Type 2 Diabetic Patients

●The Effects of Short Term Oral Proimmune - 200 in Healthy Adults: A Pilot Study

●Study of the Nutrigenomic Response of Vitamin D Supplementation in African Americans

●Immunogenicity and Safety of SARS-CoV-2 Recombinant Protein Vaccine with AS03 Adjuvant in Adults 18 Years of Age and Old

●A randomized controlled study to assess SARS CoV-2 infection, viral shedding, and subsequent potential transmission in individuals immunized with Moderna COVID-19 Vaccine

Lectures and Presentations

●Tareen N, Fong RL, Pan D, Martins D, Norris KC: Presentation of Clinical Characteristics of Older and Younger Patients with Hypertensive Emergencies. RCMI Program Directors’ Meeting, King-Drew Medical Center, Los Angeles, CA., 1/99.

●Tareen N, Fong RL Martins D, Pan D, Norris KC: The Vascular Overload Index versus Mean Arterial Pressure: Implications for Treating Older Patients with Hypertensive Emergencies. RCMI Program Directors’ Meeting, King-Drew Medical Center, Los Angeles, CA.,3/99.

●Tareen N, Fong RL, Martins D, Pan D, Norris, KC: The Vascular Overload Index versus Mean Arterial Pressure: Implications for Treating Hypertensive Emergencies in Aging Populations. UCLA Soloman Scholars Resident Research Forum, Los Angeles, CA., 5/99 (Oral Presentation)

●Tareen N, Fong RL, Martins D, Pan D, Norris, KC: The Vascular Overload Index versus Mean Arterial Pressure: Implications for Treating Hypertensive Emergencies in Aging Populations. UCLA Soloman Scholars Resident Research Forum, Los Angeles, CA., 5/99 (Oral Presentation)

●Tareen N, Fong RL, Pan D, Martins D, Norris KC: Presenting Clinical Characteristics of Older and Younger Patients with Hypertensive Emergencies. RCMI Program Directors’ Meeting, King- Drew Medical Center, Los Angeles, CA., 1/99.

●Tareen N, Martins D, Pan D, Norris KC: Isolated Systolic Hypertension and Body Mass Index in Older Subjects. RCMI Conference, King-Drew Medical Center, Los Angeles, CA.,2000.

●Tareen N: Cocaine Use and Chronic Renal Failure - seminars in nephrology, King-Drew Medical Center, Los Angeles, CA., July, 2001.

●Tareen N: The Epidemiology of End-Stage Renal Disease Among African Americans, King- Drew Medical Center, Los Angeles, CA., Aug., 2001.

●Tareen N: The Effect of Gender on Age-Related Blood Pressure Changes and the Prevalence of Isolated Systolic Hypertension Among Older Adults: Ref.: Data From NHANES111 in The Journal of Gender-Specific Medicine, King-Drew Medical Center, Los Angeles, CA., 2001.

●Tareen N: The Relationship between Estrogen Replacement Therapy and Age- Related Blood Pressure Changes. NKF Poster Presentation Symposium in Palm Springs, CA., 9/2001.

●Tareen N: The effect of socioeconomic status on the prevalence of proteinuria: data from the third national health and nutrition examination (NHANES III) survey. (ISN Satellite conference, Prevention of Kidney Disease in Minority Groups and Emerging Nations- Focus on the Americas, November 17-20, 2003 Ensenada, Baja California, Mexico)

●Tareen N: The impact of vitamin D supplementation on serum levels of 25 (OH) D3 among adult patients with chronic kidney disease. RCMI 11th International Symposium on Health Disparities, Baltimore, MD December 2005.

●Tareen N: The Effect of Poverty and Education on the Prevalence of Albuminuria: Data from the Third National Health and Nutrition Examination (NHANES III) Survey. RCMI 11th International Symposium on Health Disparities, Baltimore, MD December 2005.

●Tareen N: Low levels of serum 25 (OH) D3 are associated with high prevalence of cardiovascular risks factors across race and ethnicity: Data from NHANES III. RCMI 11th International Symposium on Health Disparities, Baltimore, MD December 2005.

●Tareen N: Association Between low levels of 25(OH) D3 and the Prevalence of Cardiovascular Risk Factor among White American Adults using NHANES III. RCMI 11th International Symposium on Health Disparities, Baltimore, MD December 2005.

●Tareen N: Abstract submitted to ADA Jan’2009; Aggressive vs. Low Dose Inhibition of the Renin-Angiotensin System (RAS) for the Treatment of Microalbuminuria in Type 2 Diabetic Patients.

Publications and Bibliography

Researched Papers (Peer Reviewed)

●Tareen N, Fong RL, Martins D, Pan D, Norris, KC: The Vascular Overload Index Versus Mean Arterial Pressure: Implications for Treating Older Patients with Hypertensive Emergencies. Ethnicity and Disease 9:2; 315, 1999.

●Tareen N, Fong RL, Martins D, Pan D, Norris, KC: Age Related Clinical Characteristics of Patients with Hypertensive Emergencies. Ethnicity and Disease 9; 315, 1999

●Tareen N, Martins D, Nelson K, Pan D, and Norris KC: The effect of gender on age- related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: Data from NHANES III. J Gend Specif Med 2001;4(3):10-13

●Tareen N: Cocaine use and chronic renal failure. Seminars in Nephrology 2001;21(4);362-366.

●Martins D, Tareen N, Pan D, and Norris KC: The relationship between body mass index and pulse pressure in older adults with isolated systolic hypertension. Am J Hypertens 2002;15:538-543

●Martins D, Tareen N, and Norris KC: The Epidemiology of end-stage renal disease among African Americans. Am J Med Sci 2002;323(2):65-71

●Martins D, Tareen N, Pan D, and Norris KC: The relationship between body mass index, blood pressure and pulse rate among normotensive and hypertensive participants in the third NHANES. Cell and Molecular Biology. 2003; 49(8)1305-1309

●Martins D, Tareen N, Nicholas SB, Jones L, Norris KC: Education, Motivation and Medication for African Americans: Bringing Hypertension Guidelines to Practice. Ethn Dis. 2004;14 [suppl 2]:s2- 38 - s2-41.

●Nicholas SB, Tareen N, Martins D, Norris KC: Calcium Antagonist: A more expansive role in treating persons with reduced kidney function? Ethn Dis. 2004;14[suppl 2]:s2-42 s2-45.

●Tareen N: The Relationship between body mass index and pulse pressure in older adults with isolated systolic hypertension. Am J Hyperts 2002;15:538-543

●Tareen N: The effect of age on the relationship between pulse rate and blood pressure. AJH. 2003;5(2)P523

●Tareen N: Alterations in acid-base homeostasis with aging. JNMA 2004;96(7) 921- 926.

●Tareen N, Martins D, Nagami G, Levine B, Norris KC: Sodium disorders in the elderly.JNMA 2005;97

●Tareen N, Martins D, Zadshir A, Pan D, Norris KC: Routine vitamin supplementation on serum levels of 25 (OH) D3 among the general adult population and patients with chronic kidney disease. Ethn Dis. 2005 Autumn;15(4 Suppl 5):S5-102-6.

●Zadshir A, Tareen N, Deyu P, Martins D: The Prevalence of hypovitaminosis D among US Adults: Data from the NHANES

●Tareen N, Zadshir A, Martins D, Pan D, Vargas R, Nissenson A, Norris KC: The Effect of Poverty and Education on the Prevalence of Albuminuria: Data from the Third National Health and Nutrition Examination (NHANES III) Survey .Am J Kidney Dis. 2006;47(6):965-971

●Tareen N, Zadshir A, Martins D, Pan D, Norris KC: The impact of vitamin D supplementation on serum levels of 25 (OH) D3 among adult patients with chronic kidney disease. Ethn Dis. 2005 Autumn;15(4 Suppl 5):S5-102-6

●Martins D, Tareen N, Ogedegbe G, Pan D, Norris KC: The Relative Risk of Cardiovascular Death Among Racial and Ethnic Minorities with Metabolic Syndrome: Data from the National Health and Nutrition Examination Survey (NHANES II) mortality follow-up (NH2MS) JNMA

●Mehrotra R, Norris KC, Tareen N: Prevalence of Cardiovascular Risk Factors and Serum Levels of 25-Hydroxyvitamin D in the United States: Data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007;167:1159-116

●Norris KC, Tareen N, Martins D: Implications of ethnicity for the treatment of hypertensive kidney disease, with an emphasis on African Americans. Nat Clin Pract Nephrol, 2008 4(10): 538-549

●Tareen N, Duran P, Davidson M: Aggressive vs. Low Dose Inhibition of the Renin-Angiotensin System (RAS) for the Treatment of Microalbuminuria in Type 2 Diabetic Patients: International Scholarly Research Network ISRN Endocrinology Volume 2011, Article ID 696124, 6 pages

Contact this candidate